digest
Short Summary
Main recommendation: Discuss Kerendia (finerenone) with your doctor if you have diabetic chronic kidney disease and your urine albumin is above 30, since Dr. Ergin describes it as the first FDA-approved drug for this condition that, per studies, slows kidney progression and lowers heart risk. The video frames the decision as weighing its benefits against its risks, especially high potassium.
Key Points
- Kerendia is a mineralocorticoid receptor antagonist (also called an aldosterone antagonist) that blocks aldosterone from binding to its receptor, reducing inflammation and fibrosis in the kidneys, heart, and blood vessels.
- It is described as not a steroid, which the speaker says means fewer hormone-related side effects than older agents like spironolactone or eplerenone.
- Beyond slowing kidney disease progression and lowering the risk of end-stage kidney disease, the speaker says studies show it also reduces heart attack, stroke, and hospitalization for heart failure.
- Chronic kidney disease cannot be cured or reversed; the goal is to prevent further damage and progression to dialysis.
- The most common complication is high potassium, which can cause muscle pain, arrhythmias, and cardiac arrest if it goes too high.
Details Worth Noting
- Concrete instructions: Before starting, check that potassium is below 5, since the speaker says not to start Kerendia if potassium is 5 or more. Have your potassium monitored about one month after starting, and keep up regular blood tests. Ask your pharmacist whether any current prescriptions are CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole, fluconazole, diltiazem) or inducers (e.g., phenobarbital, phenytoin, carbamazepine), and tell your doctor if so. Avoid grapefruit or grapefruit juice while taking it.
- Monitor for early kidney warning signs: rising albumin in urine (microalbuminuria) is the first signal to act on, and the speaker advises starting action immediately when it rises.
- Common chronic kidney disease symptoms that can appear late include changes in urine output, shortness of breath, leg and ankle swelling, fatigue, and high blood pressure.
- Drugs that can raise kidney disease risk, according to the speaker, include daily NSAIDs such as ibuprofen and long-term proton pump inhibitors such as Prilosec.
- ACE inhibitors (e.g., lisinopril) and ARBs (e.g., losartan) can interact with Kerendia, but the speaker says this is manageable with doctor-monitored potassium levels, as most study participants were already taking them safely.
- The speaker says insurance coverage was poor as of early 2022 and suggests manufacturer vouchers or coupons may help with cost; the exact retail price was not given.
Bottom Line
Kerendia is presented as a targeted option for diabetic kidney disease with added heart benefits, but it requires careful potassium monitoring and a check of your other medications before use, so the decision should be made with your doctor.
